AssayIndex
Reports by quarter

Reports submitted in 2024-Q4

Impurity-fingerprint matching introduced; first shared-bulk links published. Median purity for the quarter is 98.97 % area, n=434. Read the 2024-Q4 state-of-the-index report →

434 records11 pagesmedian on this page 98.92 %updated 30 Jul 2026
020406092.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=095.50–95.75 %: n=095.75–96.00 %: n=096.00–96.25 %: n=096.25–96.50 %: n=096.50–96.75 %: n=396.75–97.00 %: n=597.00–97.25 %: n=397.25–97.50 %: n=997.50–97.75 %: n=1297.75–98.00 %: n=2898.00–98.25 %: n=3498.25–98.50 %: n=3598.50–98.75 %: n=4098.75–99.00 %: n=5399.00–99.25 %: n=4599.25–99.50 %: n=5299.50–99.75 %: n=4499.75–100.00 %: n=71median 98.97 Purity (% area) Reports
Figure. Purity distribution for reports submitted in 2024-Q4. n=434, median 98.97 % area. Same fixed 92–100 % domain as every other purity histogram on this site, so quarters can be compared by eye.
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-018609IpamorelinQYBQYB-2407-E5509Janoshik2024-Q499.723.32104.3Supplier-supplied0PASS
AX-2025-021005GHRP-6WXTWXT-2411-G3549Nordanalyt2024-Q498.943.4689.4Supplier-supplied3FAIL
AX-2025-019824Enclomiphene citrateSWBSWB-2410-V4278Janoshik2024-Q499.726.07—Supplier-supplied1FAIL
AX-2025-019204SS-31 (Elamipretide)TFCTFC-2410-F6246VendorInvestigate2024-Q498.875.19104.3Laboratory-retained1MARGINAL
AX-2025-021006GHRP-6WXTWXT-2411-G3549Janoshik2024-Q498.483.1089.1Supplier-supplied3FAIL
AX-2025-020626TB-500SSASSA-2406-H7478Janoshik2024-Q498.964.84—Supplier-supplied2MARGINAL
AX-2025-020440CJC-1295 (no DAC)KPKP-2411-Y4921PeptideMeter2024-Q498.563.29—Supplier-supplied2MARGINAL
AX-2025-020882Kisspeptin-10CPCCPC-2411-W1680Janoshik2024-Q497.924.06102.0Buyer-sourced2FAIL
AX-2025-020497SemaglutideKPKP-2406-P6131VendorInvestigate2024-Q497.864.94—Buyer-sourced1MARGINAL
AX-2025-019581SS-31 (Elamipretide)HomopeptideHOMO-2410-K1981Kestrel2024-Q499.933.72104.6Supplier-supplied0PASS
AX-2025-021004GHRP-6WXTWXT-2411-G3549Janoshik2024-Q499.483.5890.5Supplier-supplied2MARGINAL
AX-2025-019264ExenatideTFCTFC-2409-W5949Janoshik2024-Q499.932.01101.1Supplier-supplied0PASS
AX-2025-019125TB-500JEEPJEEP-2408-V4075Kestrel2024-Q499.935.63—Supplier-supplied1MARGINAL
AX-2025-020881Kisspeptin-10CPCCPC-2411-W1680Medutest2024-Q497.894.2992.8Buyer-sourced2FAIL
AX-2025-019194ARA-290TFCTFC-2410-N5362Janoshik2024-Q499.873.3490.7Supplier-supplied1MARGINAL
AX-2025-019105MK-677 (Ibutamoren mesylate)JEEPJEEP-2406-M4461Nordanalyt2024-Q499.145.17—Supplier-supplied1FAIL
AX-2025-018526SurvodutideWWBWWB-2408-T3710Janoshik2024-Q498.673.67—Supplier-supplied1MARGINAL
AX-2025-019106GHRP-2JEEPJEEP-2405-A3970VendorInvestigate2024-Q498.464.71—Buyer-sourced1FAIL
AX-2025-019031LeuprolideJEEPJEEP-2408-K3061PeptideMeter2024-Q499.064.69—Supplier-supplied1MARGINAL
AX-2025-020375BPC-157MKMMKM-2405-C3582Janoshik2024-Q499.664.08105.0Supplier-supplied0PASS
AX-2025-019104MK-677 (Ibutamoren mesylate)JEEPJEEP-2406-M4461PeptideMeter2024-Q499.605.75—Supplier-supplied1FAIL
AX-2025-019089TB-500JEEPJEEP-2407-K3892Janoshik2024-Q498.855.3496.4Supplier-supplied2FAIL
AX-2025-018994OxytocinFGPFGP-2406-W1827Janoshik2024-Q499.554.26—Supplier-supplied0PASS
AX-2025-020883Kisspeptin-10CPCCPC-2411-W1680VendorInvestigate2024-Q497.943.7495.4Buyer-sourced2FAIL
AX-2025-020217HexarelinGGPepsGGPE-2410-U1370Janoshik2024-Q498.904.66—Buyer-sourced0FAIL
AX-2025-020088RetatrutideGGPepsGGPE-2411-R7895Nordanalyt2024-Q499.355.53—Supplier-supplied2MARGINAL
AX-2025-020726SemaglutideSGNSGN-2409-F8648Janoshik2024-Q498.114.69—Buyer-sourced0PASS
AX-2025-020089RetatrutideGGPepsGGPE-2411-R7895Janoshik2024-Q499.495.54—Supplier-supplied2MARGINAL
AX-2025-021286CJC-1295 with DACBCHBCH-2406-E7351Kestrel2024-Q498.114.84100.2Supplier-supplied2MARGINAL
AX-2025-019812BPC-157HJHJ-2407-D4137VendorInvestigate2024-Q499.207.7595.1Buyer-sourced1MARGINAL
AX-2025-019046RetatrutideJEEPJEEP-2411-F3745Janoshik2024-Q497.985.48—Supplier-supplied1MARGINAL
AX-2025-018829CJC-1295 (no DAC)QSCQSC-2410-L8549Janoshik2024-Q498.656.41100.9Supplier-supplied2MARGINAL
AX-2025-021151RetatrutideWXTWXT-2407-A5417PeptideMeter2024-Q497.733.99101.3Supplier-supplied3MARGINAL
AX-2025-020441CJC-1295 (no DAC)KPKP-2411-Y4921Medutest2024-Q499.593.9494.9Supplier-supplied2MARGINAL
AX-2025-018525SurvodutideWWBWWB-2408-T3710Medutest2024-Q498.724.0294.7Supplier-supplied1MARGINAL
AX-2025-020627TB-500SSASSA-2406-H7478PeptideMeter2024-Q498.384.78—Supplier-supplied2FAIL
AX-2025-020491IpamorelinKPKP-2409-N5350Kestrel2024-Q499.294.39—Supplier-supplied2MARGINAL
AX-2025-019103MK-677 (Ibutamoren mesylate)JEEPJEEP-2406-M4461Medutest2024-Q499.935.0399.9Supplier-supplied1FAIL
AX-2024-005494CJC-1295 with DACBCHBCH-2406-E7351Janoshik2024-Q498.584.77—Supplier-supplied2MARGINAL
AX-2024-005480TirzepatideBCHBCH-2407-F6722PeptideMeter2024-Q497.314.9790.0Supplier-supplied2MARGINAL